Potassium sparing by amiloride during thiazide therapy in hypertension
- 1 August 1984
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 36 (2) , 197-200
- https://doi.org/10.1038/clpt.1984.162
Abstract
Several studies showed that 5 mg amiloride can counteract the hypokalemic effect of 50 mg hydrochlorothiazide (HCTZ). In a double-blind study of 30 subjects with mild to moderate primary hypertension, whether this effect could be obtained with half the dose of amiloride (2.5 mg) in combination with 25 mg HCTZ was determined. The effect of twice the dosage was evaluated in subjects with unsatisfactory blood pressure (BP) on the lower dose. Both 25 mg HCTZ/amiloride 2.5 mg and 25 mg HCTZ alone lowered BP. In subjects with untreated diastolic BP between 110 and 115 mm Hg, these doses were inadequate; twice the dose resulted in a greater reduction in BP. Irrespective of dosage, a K-sparing effect resulted from the combination of HCTZ and amiloride, with a reduction in serum K levels from HCTZ alone as well.This publication has 5 references indexed in Scilit:
- Timolol and hydrochlorothiazide-amiloride in primary hypertensionClinical Pharmacology & Therapeutics, 1980
- Dose response to chlorthalidone in patients with mild hypertension; Efficacy of a lower doseClinical Pharmacology & Therapeutics, 1978
- Plasma Renin Activity, Aldosterone and Sodium Excretion in Women with High and Low Casual Blood Pressure LevelsActa Medica Scandinavica, 1978
- Low doses of hydrochlorothiazide in hypertensionEuropean Journal of Clinical Pharmacology, 1976
- Pharmacological effects in animals and normal human subjects of the diuretic amiloride hydrochloride (MK‐870>Clinical Pharmacology & Therapeutics, 1968